Flagship explainer
What drives NUTRA PHARMA CORP.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$2M | FY2025 |
| |
| Income before tax | −$2M | FY2025 |
|
| Operating income | −$1.5M | FY2025 |
|
| $257612 | FY2025 |
| |
| Ending assets | $584558 | FY2025 |
|
| Beginning assets | $599495 | FY2024 |
|
| −$16.8M | FY2025 |
| |
| −$14.8M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001493152-26-024641